Search clinical trials for: c-Met positive

Total 11462 results

Sheba Medical Center

Unknown

Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study

Infants With Positive GBS Bacteremia
Taichung Veterans General Hospital
Ton General Hospital

Unknown

Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion

Tuberculosis | Empyema | Malignant Pleural Effusion | Tuberculous Pleurisy

China
Taichung Veterans General Hospital
Centers for Disease Control and Prevention; ChungHwa Veterans house; Taiwan Province...

Unknown

Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers

Latent Tuberculosis | Tuberculosis | Elderly | Tuberculosis Contact

China
Taichung Veterans General Hospital

Unknown

Development of Tuberculosis Diagnostic Kit

Pneumonia | Lung Cancer | Tuberculosis

Taiwan
Assistance Publique - Hôpitaux de Paris

Unknown

Local Anesthesia and Tuberculin Skin Test in Infants and Children

Tuberculosis

France
Hvidovre University Hospital
Danish Lung Association; Copenhagen Hospital Corporation; The Danish Rheumatism...

Unknown

Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis

HIV Infections | Rheumatoid Arthritis | Tuberculosis

Denmark
Pronova BioPharma

Completed

Omacor and Placebo in Carotid Plaque Stability

Cardiovascular Disease

United Kingdom
Brooke Army Medical Center
GlaxoSmithKline; Becton, Dickinson and Company

Completed

An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers

Cellulitis | Folliculitis | Abscesses | Community-Acquired MRSA Infections

United States
Savient Pharmaceuticals
Neurologic AIDS Research Consortium (NARC)

Terminated

Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients

HIV | Peripheral Nervous System Disorders
Nagoya University

Unknown

Improvement in Baroreflex Sensitivity in OSAS

Obstructive Sleep Apnea Syndrome

Japan
Nagoya University

Completed

BiPAP for Cardiomyopathy With Central Sleep Apnea

Dilated Cardiomyopathy

Japan
VaxGen
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

Anthrax

United States
Sociedad Española de Neumología y Cirugía Torácica

Unknown

Spanish Cohort for the Study of the Effect of CPAP in Hypertension (CEPECTA)

Hypertension | Sleep Apnea

Spain
Poitiers University Hospital
Novartis

Completed

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Chronic Myeloid Leukemia

France
National Health Research Institutes, Taiwan

Completed

The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population

Tuberculosis

Taiwan
Poitiers University Hospital
Novartis; Ministry of Health, France

Terminated

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Chronic Myeloid Leukemia

France
Zeneus Pharma

Unknown

Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Italy
Johns Hopkins Bloomberg School of Public Health

Completed

AMR of Streptococcus Pneumoniae Carriage Strains

Infection
University of Cape Town
Aeras; Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan.

Unknown

Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.

Tuberculosis

South Africa
Tokyo Study Group

Completed

Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes

GAD Ab Positive Clinically Type 2 Diabetic Patients

Japan
Centers for Disease Control and Prevention
Kaiser Permanente

Completed

Racial Disparities in Pneumococcal Vaccination in Managed Care

Pneumococcal Disease Prevention

United States
Barts & The London NHS Trust
NHS Research and Development

Unknown

Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?

Tuberculosis

United Kingdom
Institut de Recherche pour le Developpement
World Health Organization; European Commission

Unknown

A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis

Tuberculosis

Kenya, Benin, Guinea, Senegal, South Africa
Boehringer Ingelheim

Completed

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

HIV Infections

United States, Puerto Rico
Association Européenne de Recherche en Oncologie
Amgen; Aventis Pharmaceuticals

Completed

Randomized Phase II Trial of Dose Dense Docetaxel in N+ Breast Cancer

Node Positive Breast Cancer
Lymphoma Study Association

Terminated

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

CD20-Positive Large B-Cell Lymphoma

France
National Taiwan University Hospital

Unknown

PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period

Tuberculosis

Taiwan
National Taiwan University Hospital

Unknown

Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis

Tuberculosis | Monoclonal Gammopathy

Taiwan
National Taiwan University Hospital

Unknown

Diagnosis of Active Tuberculosis by ELISPOT

Tuberculosis

Taiwan
Centers for Disease Control and Prevention
University of Washington

Completed

Intervening With Children/Adolescents With FAS/ARND

Treatment | Control

United States
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Tuberculosis

United States, Canada
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Tuberculosis

United States, Canada
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

HIV Infections | Tuberculosis

United States, Canada
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Pulmonary Tuberculosis

United States, Canada
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

HIV Infections | Tuberculosis

United States, Canada
Centers for Disease Control and Prevention
US Department of Veterans Affairs

Completed

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

HIV Infections | Tuberculosis

United States, Canada
Aaron Diamond AIDS Research Center

Unknown

A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

HIV Infections

United States
Mucos Pharma GmbH and Co

Completed

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

HIV Infections

United States
Otsuka America Pharmaceutical

Completed

A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons

HIV Infections

United States
Gilead Sciences

Completed

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

HIV Infections

United States, Puerto Rico
SmithKline Beecham

Completed

A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis

HIV Infections | Protozoan Infections

United States
Glaxo Wellcome

Completed

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

HIV Infections

United States, Canada, Argentina, Brazil, Puerto Rico
Merck Sharp & Dohme LLC

Completed

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

HIV Infections

United States
Chiron Corporation

Unknown

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

HIV Infections

United States
Aaron Diamond AIDS Research Center

Completed

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

HIV Infections | Mycobacterium Avium-Intracellulare Infection | Tuberculosis, Mycobacterium Infection

United States
GlaxoSmithKline

Unknown

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

HIV Infections

United States
University of California, San Francisco

Completed

A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Hoffmann-La Roche

Completed

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

HIV Infections

Canada, United States
Gilead Sciences

Completed

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

HIV Infections

United States, Puerto Rico
Amgen

Completed

Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States

Search clinical trials for: c-Met positive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations